株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の臨床検査市場予測:検査、研究施設、疾患別

US Clinical Laboratory Testing Market By Type of Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type of Lab (Hospital, Physician, Independent), & By Type of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast to 2022

発行 RNCOS E-Services Pvt. Ltd. 商品コード 423697
出版日 ページ情報 英文 65 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.53円で換算しております。
Back to Top
米国の臨床検査市場予測:検査、研究施設、疾患別 US Clinical Laboratory Testing Market By Type of Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type of Lab (Hospital, Physician, Independent), & By Type of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast to 2022
出版日: 2017年01月12日 ページ情報: 英文 65 Pages
概要

当レポートでは、米国の臨床検査市場について分析し、主な市場促進要因や、市場動向と今後の見通し、検査別・研究施設別の詳細動向、市場発展の方向性、主要企業のプロファイルなどを調査・考察しております。

第1章 アナリストの見解

第2章 調査手法

第3章 米国の臨床検査市場の見通し

第4章 米国の臨床検査市場:検査種類別

  • 臨床化学研究室
  • ヒト・癌遺伝子研究室
  • 医療用微生物学・細胞学研究室
  • 希少・難治性疾患検査

第5章 米国の臨床検査市場:研究施設別

  • 病院内研究施設
  • 内科研究施設
  • 独立研究施設

第6章 疾患の統計データ

第7章 促進要因・市場動向

  • 高齢化の進行
  • 罹患者数の増加
  • 病気の早期発見
  • 従業員の健康プログラム
  • 事業協力・事業統合
  • イノベーションに焦点

第8章 主要企業のプロファイル

目次

The US clinical laboratories are a full service reference laboratories performing routine and specialized diagnostic testing service for physicians and patients. US represents an attractive destination for healthcare services' market segments, especially clinical lab testing, which has evolved as a major source of decisive factor for healthcare professionals and that too despite garnering a low proportion of total medical spending. It is estimated that the market for clinical lab testing in the US is poised to witness healthy growth backed by factors such as aging population, active private sector participation, and rising awareness level. With the emergence of new technologies, the market is likely to register further to an optimum CAGR in future.

Currently, the market is dominated by clinical chemistry tests, followed by human & tumor genomics. The future, however, holds significant promise for human and tumor genomics testing. The future growth in this segment is driven by strong growth in personalized laboratory testing on tumor tissues and other key factors. The report, in this context, offers effective information and analysis on the market landscape for key tests type, with special emphasis on their future performance.

Moreover, the report provides the current and future market for different types of tests. The report also divides the market on the basis of types of labs into hospital based laboratories, physician laboratories, and independent laboratories. The physician laboratories accounted for the largest share in the US clinical laboratory testing market in 2016.

The US market for clinical laboratory diagnostics is highly fragmented, with large number of labs offering services in different states of the country. Some players, however, have leading edge in comparison to other companies. Quest diagnostics, LabCorp and Sonic Healthcare are the key independent laboratories that have augmented their reach in the market with proper focus on consolidation activities. Our report entitled "US Clinical Laboratory Testing Market By Type of Test (Tumor, Clinical Chemistry, Microbiology, Esoteric), By Type of Lab (Hospital, Physician, Independent), & By Type of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast to 2022" provides an in-depth insight into the operations, services, financial performance of the key players in order to gauge their attractiveness in terms of investment and future participation in the market. Overall, the report is likely to be proved beneficial for all those entities who want to enter the market, or make decisions regarding investment.

Table of Contents

1. Analyst View

2. Research Methodology

3. US Clinical Laboratory Testing Market Outlook 2022

4. Market Segmentation by Test Type

  • 4.1 Clinical Chemistry Laboratory
  • 4.2 Human & Tumor Genetics Laboratory
  • 4.3 Medical Microbiology & Cytology Laboratory
  • 4.4 Esoteric Tests

5. Market Segmentation by Laboratories

  • 5.1 Hospital Laboratories
  • 5.2 Physician Laboratories
  • 5.3 Independent Laboratories

6. Disease Demographics

7. Drivers & Trends

  • 7.1 Growing Ageing Population
  • 7.2 Rising Disease Incidence
  • 7.3 Early Disease Detection Facilities
  • 7.4 Employer Wellness Programs
  • 7.5 Increased Health Care Spending
  • 7.6 Collaboration & Consolidation
  • 7.7 Focusing on Innovations

8. Key Players

  • 8.1 Laboratory Corporation of America (LabCorp)
  • 8.2 OPKO Health Inc.
  • 8.3 Sonic Healthcare USA
  • 8.4 Quest Diagnostics
  • 8.5 Alere Inc.
  • 8.6 Abbott Laboratories
  • 8.7 Charles River Laboratories
  • 8.8 Healthscope Ltd
  • 8.9 Genzyme (Subsidiary of Sanofi)
  • 8.10 Qiagen

List of Figures:

  • Figure 3-1: US - Clinical Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 4-1: US - Clinical Laboratory Testing Market by Test Type (%), 2016
  • Figure 4-2: US - Clinical Chemistry Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 4-3: US - Human & Tumor Genetics Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 4-4: US - Medical Microbiology & Cytology Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 4-5: US - Esoteric Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 5-1: US - Clinical laboratory Testing Market Segment by Laboratories (%), 2016
  • Figure 5-2: US - Hospital Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 5-3: US - Physician Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 5-4: US - Independent Laboratory Testing Market (Billion US$), 2016 & 2022
  • Figure 7-1: US - Population 65 Years and Above (Million), 2016 & 2060
  • Figure 7-2: US - Prevalence of Cancer (Million), 2014 & 2024.
  • Figure 7-3: US - Number of Closed M&A Deals in Lab Industry (2001-2013)
  • Figure 8-1: LabCorp - Net Revenue by Segment (%), 2015
  • Figure 8-2: LabCorp - Net Revenue by Geography (%), 2015
  • Figure 8-3: OPKO Health Inc. - Revenue by Geography (%), 2015
  • Figure 8-4: Sonic Healthcare - Revenue by Segment (%), 2016
  • Figure 8-5: Sonic Health - Revenue by Geography (%), 2016
  • Figure 8-6: Alere Inc. - Revenue by Segment (%), 2015
  • Figure 8-7: Alere Inc. - Revenue by Geography (%), 2015
  • Figure 8-8: Abbott - Net Sales by Segment (%), 2015
  • Figure 8-9: Abbott - Net Sales by Geography (%), 2015
  • Figure 8-10: Charles River Laboratories - Revenue by Segment (%), 2015
  • Figure 8-11: Charles River Laboratories - Revenue by Geography (%), 2015
  • Figure 8-12: Healthscope Ltd. - Revenue by Segment (%), 2016
  • Figure 8-13: Sanofi - Net Sales by Geography (%), 2015
  • Figure 8-14: Qiagen - Net Sales by Segment (%), 2015
  • Figure 8-15: Qiagen - Net Sales by Geography (%), 2015

List of Tables:

  • Table 6-1: US - Tuberculosis Incidences (2014 & 2015)
  • Table 6-2: US - Influenza Incidences (2013 & 2014)
  • Table 6-3: US - HIV/AIDS Incidences (2013 & 2014)
  • Table 6-4: US - Gonorrhea Incidences (2013, 2014 & 2015)
  • Table 6-5: US - Cirrhosis Incidences (2013 & 2014)
  • Table 6-6: US - Kidney Diseases Incidences (2013 & 2014)
  • Table 6-7: US - Cancer Incidences (2013, 2014 & 2015)
  • Table 8-1: LabCorp - Financials (Million US$), 2013, 2014 & 2015
  • Table 8-2: OPKO - Financials (Million US$), 2013, 2014 & 2015
  • Table 8-3: Sonic Healthcare - Financials, (Million US$), 2014, 2015 & 2016
  • Table 8-4: Quest Diagnostics - Financials, (Million US$), 2013, 2014 & 2015
  • Table 8-5: Alere Inc. - Financials (Million US$), 2013, 2014 & 2015
  • Table 8-6: Abbott - Financials (Million US$), 2013, 2014 & 2015
  • Table 8-7: Charles River Laboratories - Financials (Million US$), 2013, 2014 & 2015
  • Table 8-8: Healthscope Ltd. - Financials (Million US$), 2014, 2015 & 2016
  • Table 8-9: Sanofi - Financials (Million US$), 2013, 2014 & 2015
  • Table 8-10: Qiagen - Financials (Million US$), 2013, 2014 & 2015
Back to Top